Skip to main content
OpenTrials
Completed

NCT Number: NCT06006260

Changes of Low Anterior Resection Syndrome and Balance Ability in Patients With Rectal Cancer.

The purposes of this study are to explore the trajectory of symptom distress and balance ability in patients with rectal cancer.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Chung Gung University

Taoyuan City, Kwei-Shan Dist., 333, Taiwan

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Newly diagnosed rectal cancer
  • Patients already know their condition.
  • Aged 20 years and older.
  • Consciously communicate in Mandarin or Taiwanese.
  • Agreed with the interview and had signed the permit.

Exclusion criteria

  • Recurrent rectal cancer.
  • KPS of patients less than 80

Treatment and study plan

Primary outcomes

  1. Self-report Questionnaire

    Time frame: Change from baseline symptom at 2 months

    Show the specific trajectory of LAR Syndrome, psychological distress, fecal incontinence-related QoL, and balance ability based on different tumor locations in patients with rectal cancer

Sponsors and collaborators

Lead sponsor

Chang Gung Memorial Hospital

Other

Registry information

Official study title

Changes of Low Anterior Resection Syndrome, Balance Ability, and Quality of Life in Patients With Newly Diagnosed Rectal Cancer.

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Aug 23, 2023
Registry last updated
Mar 20, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.